Dudediligence.

Exicure, Inc

XCURNASDAQ · Pharmaceutical Preparations
Write an idea

Price

From the filings

Figures

Revenue
$0.00last 12 months
Net income
−$8.3Mlast 12 months
Operating cash flow
−$8.1Mlast 12 months
Cash and equivalents
$1.7Mat the last balance sheet
Shares outstanding
6.4M shareson issue
Every year and quarter →